2024-2029 Africa Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 7 Countries--2023 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

October 2024 | - | ID: 2E628447EC0EEN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by country, section, and can be customized to specific information needs and budget.This new report from LeadingMarketResearch provides a comprehensive analysis of the Africa therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays:Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin.During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
The report provides segment test volume and sales forecasts for the following tests:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran,
Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
and Warfarin.
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alfa
Wassermann, AMS, Awareness Technologies, Beckman
Coulter, Binding Site, bioMerieux, Carolina Chemistries,
DiaSorin, Grifols, Horiba, Medica, Nova Biomedical,
Ortho-Clinical Diagnostics, Polymedco, Randox, Roche,
Siemens Healthineers, Tosoh, Vital Diagnostics and
other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential
Applications

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays
-Overview
-ELISA
-EMIT
-Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

3. TANDEM MASS SPEC

4. IT AND AUTOMATION

5. DRY CHEMISTRY

6. BIOSENSORS

Table of Contents (Continued)
France: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Table of Contents (Continued)
Spain: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
USA: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges